Callan Capital, LLC Becton Dickinson & CO Transaction History

Callan Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$225.07 - $246.17 $13,729 - $15,016	61 Added 0.87%	7,100 $1.66 Million
Q1 2024 Oct 22, 2024	SELL	$233.45 - $247.73 $14,240 - $15,111	-61 Reduced 0.86%	7,039 $1.74 Million
Q1 2024 May 03, 2024	BUY	$233.45 - $247.73 $34,784 - $36,911	149 Added 2.16%	7,039 $1.74 Million
Q4 2023 Feb 02, 2024	SELL	$232.24 - $267.23 $2,322 - $2,672	-10 Reduced 0.14%	6,890 $1.68 Million
Q3 2023 Nov 06, 2023	BUY	$254.9 - $283.59 $14,529 - $16,164	57 Added 0.83%	6,900 $1.78 Million
Q2 2023 Aug 04, 2023	SELL	$238.39 - $265.32 $76,046 - $84,637	-319 Reduced 4.45%	6,843 $1.81 Million
Q1 2023 Jun 13, 2023	SELL	$229.71 - $259.35 $3,445 - $3,890	-15 Reduced 0.21%	7,162 $1.77 Million
Q1 2023 May 08, 2023	SELL	$229.71 - $259.35 $3,445 - $3,890	-15 Reduced 0.21%	7,162 $1.77 Million
Q4 2022 Jun 13, 2023	BUY	$218.29 - $256.91 $3,274 - $3,853	15 Added 0.21%	7,177 $1.83 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $1.57 Million - $1.84 Million	7,177 New	7,177 $1.83 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Callan Capital, LLC with notifications on news.